Absolutely: Velcade (bortezomib) is available in the us for treatment of multiple myeloma and mantle cell non-hodgkin lymphoma. It can now be given either intravenously or subcutaneously which lessens many of its side effects.
Answered 7/3/2012
5.8k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question